1,501,044 Shares in ASP Isotopes Inc. (NASDAQ:ASPI) Acquired by CenterBook Partners LP

CenterBook Partners LP acquired a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 1,501,044 shares of the company's stock, valued at approximately $6,800,000. CenterBook Partners LP owned approximately 2.10% of ASP Isotopes at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Hanson & Doremus Investment Management purchased a new position in shares of ASP Isotopes during the 4th quarter worth about $27,000. Avantax Advisory Services Inc. purchased a new stake in shares of ASP Isotopes during the fourth quarter valued at $45,000. Russell Investments Group Ltd. grew its stake in ASP Isotopes by 56.3% in the 4th quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock worth $46,000 after acquiring an additional 3,682 shares in the last quarter. SVB Wealth LLC purchased a new position in shares of ASP Isotopes during the fourth quarter worth approximately $49,000. Finally, Boston Financial Mangement LLC bought a new stake in shares of ASP Isotopes during the fourth quarter valued at approximately $50,000. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Trading Up 0.5 %

Shares of NASDAQ ASPI traded up $0.03 during trading hours on Monday, reaching $6.02. The stock had a trading volume of 1,812,148 shares, compared to its average volume of 2,289,809. ASP Isotopes Inc. has a 52-week low of $1.86 and a 52-week high of $9.33. The firm has a market cap of $433.85 million, a price-to-earnings ratio of -9.87 and a beta of 3.44. The business's fifty day moving average price is $4.75 and its two-hundred day moving average price is $5.10. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.